New hope for PMR patients: drug may reduce need for steroids
NCT ID NCT05533125
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether rituximab, a drug that calms the immune system, can help people with polymyalgia rheumatica (PMR) stop taking steroids sooner. PMR causes pain and stiffness, and steroids are the main treatment but have side effects. The trial included 114 newly diagnosed patients and compared rituximab to a placebo, with the goal of seeing if more patients could achieve remission without steroids after one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYMYALGIA RHEUMATICA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sint Maartensklineik
Ubbergen, Gelderland, 6574 NA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New tool could predict who will suffer from steroid side effects
- New drug could ease painful muscle condition and cut steroid use
- New drug could help patients with painful muscle disease ditch steroids
- New study aims to unravel mysteries of common inflammatory condition in older adults
- New study links common arthritis treatments to diabetes risk
- Stress relief: could a simple hormone boost ease fatigue in PMR/GCA patients?